FRANCES A NARVAIZ
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner SAN ANTONIO, TX NPI 1376046532
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner TX Novo Nordisk AS All categories
General Payments — all program years on this page
$3,064.36
- Category: General Payments
- Program years: PY2021–2024
- Record count: 161
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,458.03 across 63 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,458.03 | 63 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $338.41 | 16 |
| Abbott Laboratories | $154.22 | 2 |
| BOSTON SCIENTIFIC CORPORATION | $133.21 | 2 |
| PFIZER INC. | $108.95 | 6 |
| Lilly USA, LLC | $89.10 | 4 |
| Teva Pharmaceuticals USA, Inc. | $82.96 | 4 |
| Merck Sharp & Dohme Corporation | $69.50 | 4 |
| MDD US Operations, LLC | $68.72 | 4 |
| GlaxoSmithKline, LLC. | $56.27 | 3 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $52.00 | 2 |
| Acorda Therapeutics, Inc | $51.49 | 3 |
| Acerta Pharma LLC | $43.36 | 2 |
| Amgen Inc. | $42.28 | 2 |
| ABBVIE INC. | $34.85 | 2 |
| Azurity Pharmaceuticals, Inc. | $32.28 | 2 |
| Merz Pharmaceuticals, LLC | $29.03 | 1 |
| Exact Sciences Corporation | $20.86 | 1 |
| Neurocrine BioSciences, Inc. | $19.70 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $15.86 | 1 |
| SCILEX PHARMACEUTICALS INC. | $14.98 | 1 |
By program year
Records — PY2024 (63)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.